Related Experiment Video
Updated: Jan 14, 2026

06:27
A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
Published on: May 9, 2025
1.1K
AOSNP-ADAPTR resource level-based recommendations on practical diagnostic strategies for WHO CNS5 adult-type diffuse
Vani Santosh1, Chitra Sarkar2, Shilpa Rao1
1Department of Neuropathology, National Institute of Mental Health and Neuro Sciences, Bengaluru, India.
Brain Pathology (Zurich, Switzerland)
|October 27, 2025
Summary
New guidelines offer practical approaches for diagnosing adult-type diffuse gliomas (ADGs) in resource-limited settings, adapting WHO CNS5 criteria using histology and immunohistochemistry when molecular testing is not feasible.
Area of Science:
- Neuropathology
- Oncology
- Global Health
Background:
- The WHO CNS5 classification integrates molecular data for Adult-type Diffuse Gliomas (ADGs), posing challenges for resource-limited regions.
- Molecular diagnostics are crucial but often inaccessible in Low-Income Countries (LICs) and Lower Middle-Income Countries (LMICs) due to cost and technical barriers.
Purpose of the Study:
- To develop resource-stratified recommendations for diagnosing ADGs in resource-restrained settings.
- To adapt the WHO CNS5 guidelines for practical application in regions with limited diagnostic capabilities.
Main Methods:
- The Asian Oceanian Society of Neuropathology (AOSNP) initiative 'ADAPTR' defined Resource Levels (RLs) from I to V.
- Recommendations were created for a 'Histology-oriented integrated diagnosis format' and diagnostic flow charts for ADGs at different RLs.
- Emphasis was placed on histopathology and immunohistochemistry, with molecular testing recommendations tiered as 'can be considered,' 'highly recommended,' or 'obligatory.'
Main Results:
- ADAPTR provides practical diagnostic approaches for ADGs tailored to varying resource levels (RL I-IV for LMICs).
- Each RL offers either a WHO CNS5 diagnosis with CNS WHO grade or an ADAPTR descriptive diagnosis with an ADAPTR histologic grade.
- The recommendations facilitate diagnosis by prioritizing accessible techniques while outlining the role of molecular testing.
Conclusions:
- ADAPTR offers a feasible adaptation of WHO CNS5 guidelines for routine neuropathology practice in resource-restrained regions.
- These recommendations aim to improve ADG diagnosis and grading in settings facing diagnostic limitations.
- The initiative supports consistent diagnostic practices aligned with global standards despite resource constraints.

